Pharmaceutical / Drug Definition :
Inhibits COMT, the primary enzyme involved in metabolizing levodopa. This inhibition increases levodopa blood level and duration of action, easing symptoms of Parkinson's disease.
In the United States, Entacapone is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Entacapone.
Registrar Corp assists Entacapone companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Entacapone (Entacapone Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Entacapone (Entacapone Suppliers)
- Processors Entacapone
- Repackers Entacapone
- Relabelers Entacapone
- Exporters Entacapone
- Importers Entacapone
For more information about Entacapone, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.